181 related articles for article (PubMed ID: 15345319)
1. Cyclic antimicrobial peptides based on Limulus anti-lipopolysaccharide factor for neutralization of lipopolysaccharide.
Andrä J; Lamata M; Martinez de Tejada G; Bartels R; Koch MH; Brandenburg K
Biochem Pharmacol; 2004 Oct; 68(7):1297-307. PubMed ID: 15345319
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of interaction of optimized Limulus-derived cyclic peptides with endotoxins: thermodynamic, biophysical and microbiological analysis.
Andrä J; Howe J; Garidel P; Rössle M; Richter W; Leiva-León J; Moriyon I; Bartels R; Gutsmann T; Brandenburg K
Biochem J; 2007 Sep; 406(2):297-307. PubMed ID: 17501719
[TBL] [Abstract][Full Text] [Related]
3. A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo.
Ren JD; Gu JS; Gao HF; Xia PY; Xiao GX
Int Immunopharmacol; 2008 Jun; 8(6):775-81. PubMed ID: 18442780
[TBL] [Abstract][Full Text] [Related]
4. Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin.
Brandenburg K; Jürgens G; Müller M; Fukuoka S; Koch MH
Biol Chem; 2001 Aug; 382(8):1215-25. PubMed ID: 11592403
[TBL] [Abstract][Full Text] [Related]
5. Biophysical characterization of the interaction of Limulus polyphemus endotoxin neutralizing protein with lipopolysaccharide.
Andrä J; Garidel P; Majerle A; Jerala R; Ridge R; Paus E; Novitsky T; Koch MH; Brandenburg K
Eur J Biochem; 2004 May; 271(10):2037-46. PubMed ID: 15128313
[TBL] [Abstract][Full Text] [Related]
6. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities.
Schumann RR; Lamping N; Hoess A
J Immunol; 1997 Dec; 159(11):5599-605. PubMed ID: 9548502
[TBL] [Abstract][Full Text] [Related]
7. Structure of a synthetic fragment of the LALF protein when bound to lipopolysaccharide.
Pristovsek P; Fehér K; Szilágyi L; Kidric J
J Med Chem; 2005 Mar; 48(5):1666-70. PubMed ID: 15743208
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of endotoxin neutralization by synthetic cationic compounds.
Andrä J; Gutsmann T; Garidel P; Brandenburg K
J Endotoxin Res; 2006; 12(5):261-77. PubMed ID: 17059690
[TBL] [Abstract][Full Text] [Related]
9. Comparison of endotoxin antagonism of linear and cyclized peptides derived from limulus anti-lipopolysaccharide factor.
Leslie DB; Vietzen PS; Lazaron V; Wasiluk KR; Dunn DL
Surg Infect (Larchmt); 2006 Feb; 7(1):45-52. PubMed ID: 16509785
[TBL] [Abstract][Full Text] [Related]
10. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor.
Weiss CA; Wasiluk KR; Kellogg TA; Dunn DL
Surgery; 2000 Aug; 128(2):339-44. PubMed ID: 10923014
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide.
Andrä J; Lohner K; Blondelle SE; Jerala R; Moriyon I; Koch MH; Garidel P; Brandenburg K
Biochem J; 2005 Jan; 385(Pt 1):135-43. PubMed ID: 15344905
[TBL] [Abstract][Full Text] [Related]
13. Interaction of antimicrobial peptides with lipopolysaccharides.
Ding L; Yang L; Weiss TM; Waring AJ; Lehrer RI; Huang HW
Biochemistry; 2003 Oct; 42(42):12251-9. PubMed ID: 14567687
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide neutralization by the antibacterial peptide CM4.
Lin QP; Zhou LF; Li NN; Chen YQ; Li BC; Cai YF; Zhang SQ
Eur J Pharmacol; 2008 Oct; 596(1-3):160-5. PubMed ID: 18789317
[TBL] [Abstract][Full Text] [Related]
15. [Study of in vitro endotoxin neutralization effect and antibacterial activity of limulus anti-lipopolysaccharide factor simulated peptide REMP2].
Gao HF; Xiao GX; Xia PY; Ren JD
Zhonghua Shao Shang Za Zhi; 2008 Apr; 24(2):90-2. PubMed ID: 18785404
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide (LPS) detoxification of analogue peptides derived from limulus anti-LPS factor.
Ren J; Gao H; Tang M; Gu J; Xia P; Xiao G
Peptides; 2010 Oct; 31(10):1853-9. PubMed ID: 20624438
[TBL] [Abstract][Full Text] [Related]
17. Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor.
Warren HS; Glennon ML; Wainwright N; Amato SF; Black KM; Kirsch SJ; Riveau GR; Whyte RI; Zapol WM; Novitsky TJ
Infect Immun; 1992 Jun; 60(6):2506-13. PubMed ID: 1587618
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical and biological characterization of anti-endotoxin peptides and their influence on lipid properties.
Kowalski I; Kaconis Y; Andrä J; Razquin-Olazarán I; Gutsmann T; Martinez de Tejada G; Brandenburg K
Protein Pept Lett; 2010 Nov; 17(11):1328-33. PubMed ID: 20673224
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccaride-binding peptides obtained by phage display method.
Matsumoto M; Horiuchi Y; Yamamoto A; Ochiai M; Niwa M; Takagi T; Omi H; Kobayashi T; Suzuki MM
J Microbiol Methods; 2010 Jul; 82(1):54-8. PubMed ID: 20412822
[TBL] [Abstract][Full Text] [Related]
20. Bioactive peptides derived from the Limulus anti-lipopolysaccharide factor: structure-activity relationships and formation of mixed peptide/lipid complexes.
Mora P; López De La Paz M; Pérez-Payá E
J Pept Sci; 2008 Aug; 14(8):963-71. PubMed ID: 18383433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
